Phenotypic and genotypic assays for detecting the prevalence of metallo-β-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital
Nosocomial infections caused by Acinetobacter baumannii often prove difficult to treat owing to their multiple drug resistance. Carbapenems play a pivotal role in the management of severe Acinetobacter infections. However, reports of carbapenem resistance have been increasing alarmingly due to production of a variety of carbapenemases including metallo-β-lactamases (MBLs). This study investigated by both phenotypic and genotypic assays the prevalence of MBLs in a total of 55 A. baumannii strains isolated from a South Indian tertiary care hospital. Random amplified polymorphic DNA (RAPD) genotyping and antimicrobial susceptibility testing for nine clinically relevant antibiotics was done for characterization of isolates. Phenotypic expression of MBLs was examined by a simple double disc synergy (DDS) test, and the presence of the most frequent MBL coding genes, blaIMP1 and blaVIM2, was checked by PCR. RAPD analysis generated six clusters of isolates and there was very little correlation between RAPD clusters and resistant profiles. Most of the isolates showed complete or high resistance to imipenem (100 %), meropenem (89 %), amikacin (80 %), cefotaxime (89 %) and ciprofloxacin (72 %). In addition, 44 % of isolates showed a high MIC level (≥16 μg ml−1) for meropenem. Thirty-nine isolates (70.9 %) were positive for MBL production by the DDS test while blaIMP1 gene amplification was seen only in 23 isolates (42 %). Interestingly, none of the isolates showed amplification of blaVIM2. Further investigations on DDS-positive/PCR-negative isolates by spectrophotometric assay showed MBL activity in most of the isolates, suggesting involvement of other genes. The high incidence of isolates possessing MBL activity in the present study represents an emerging threat of complete resistance to carbapenems among Acinetobacter spp. in India.
ChandraR.,
KapilA.,
SharmaP.,
DasB.2002; Identification of Acinetobacter species isolated from clinical specimens by amplified ribosomal DNA restriction analysis. Indian J Med Res 116:1–4
D'AgataE. M.,
GerritsM. M.,
TangY. W.,
SamoreM.,
KustersJ. G.2001; Comparison of pulsed-field gel electrophoresis and amplified fragment-length polymorphism for epidemiological investigations of common nosocomial pathogens. Infect Control Hosp Epidemiol 22:550–554[CrossRef]
Da SilvaG. J.,
CorreiaM.,
VitalC.,
RibeiroG.,
SousaJ. C.,
LeitaoR.,
PeixeL.,
DuarteA.2002; Molecular characterization of bla IMP-5, a new integron-borne metallo- β -lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol Lett 215:33–39
GallegoL.,
TownerK. J.2000; Carriage of class I integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii
. In Acinetobacter 2000 , 5th International Symposium on the Biology of Acinetobacter , abstract 15 Noordwijkerhout, The Netherlands:
GuptaV.,
DattaP.,
ChanderJ.2006; Prevalence of metallo- β -lactamase (MBL) producing Pseudomonas spp. and Acinetobacter spp. in a tertiary care hospital in India. J Infect 52:311–314[CrossRef]
JesudasonM. V.,
KandathilA. J.,
BalajiV.2005; Comparison of two methods to detect carbapenemase and metallo-beta-lactamase production in clinical isolates. Indian J Med Res 121:780–783
JoshiS. G.,
LitakeG. M.,
GholeV. S.,
NiphadkarK. B.2003a; Plasmid borne extended spectrum beta-lactamase in a clinical isolate of Acinetobacter baumannii
. J Med Microbiol 52:1125–1127
KenchappaP.,
SreenivasmurthyB.2003; Simplified panel of assimilation tests for identification of Acinetobacter species. Indian J Pathol Microbiol 46:700–706
LaurettiL.,
RiccioM. L.,
MazzariolA.,
CornagliaG.,
AmicosanteG.,
FontanaR.,
RossoliniG. M.1999; Cloning and characterization of bla VIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 43:1584–1590
LeeK.,
YumJ. H.,
YongD.,
LeeH. M.,
KimH. D.,
DocquierJ. D.,
RossoliniG. M.,
ChongY.2005; Novel acquired metallo-beta-lactamase gene, bla SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 49:4485–4491[CrossRef]
LiuP. Y.,
WuW. L.1997; Use of different PCR-based DNA fingerprinting techniques and pulsed-field gel electrophoresis to investigate the epidemiology of Acinetobacter calcoaceticus-Acinetobacter baumannii complex. Diagn Microbiol Infect Dis 29:19–28[CrossRef]
ManikalV. M.,
LandmanD.,
SaurinaG.,
OydnaE.,
LalH.,
QualeJ.2000; Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, inter-institutional spread, and relation to antibiotic usage. Clin Infect Dis 31:101–106[CrossRef]
MendirattaD. K.,
DeotaleV.,
NarangP.2005; Metallo-beta-lactamase producing Pseudomonas aeruginosa in a hospital from a rural area. Indian J Med Res 121:701–703
Navon-VeneziaS.,
Ben-AmiR.,
CarmeliY.2005; Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis 18:306–313[CrossRef]
PelegA. Y.,
FranlinC.,
BellJ. M.,
SpelmanD. W.2005; Dissemination of metallo- β -lactamase gene bla IMP-4 among gram negative pathogens in a clinical setting in Australia. Clin Infect Dis 41:1549–1556[CrossRef]
PoirelL.,
NaasT.,
NicolasD.,
ColletL.,
BellaisS.,
CavalloJ. D.,
NordmannP.2000; Characterization of VIM-2, a carbapenem-hydrolyzing metallo- β -lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 44:891–897[CrossRef]
PrashanthK.,
BadrinathS.2000; Simplified phenotypic tests for identification of Acinetobacter spp. and their antimicrobial susceptibility status. J Med Microbiol 49:773–778
PrashanthK.,
BadrinathS.2004; In vitro susceptibility pattern of Acinetobacter species to commonly used cephalosporins, quinolones and aminoglycosides. Indian J Med Microbiol 22:97–103
PrashanthK.,
BadrinathS.2005; Epidemiological investigation of nosocomial Acinetobacter infections using AP-PCR and pulse field gel electrophoresis. Indian J Med Res 122:408–418
PrashanthK.,
BadrinathS.2006; Nosocomial infections due to Acinetobacter species: clinical findings, risk and prognostic factors. Indian J Med Microbiol 24:39–44[CrossRef]
SarkarB.,
BiswasD.,
PrasadR.,
SharmaJ. P.2006; A clinicomicrobiological study on the importance of Pseudomonas in nosocomially infected ICU patients, with special reference to metallo beta-lactamase production. Indian J Pathol Microbiol 49:44–48
SinhaM.,
SrinivasaH.2007; Mechanisms of resistance to carbapenems in meropenem resistant Acinetobacter isolates from clinical samples. Indian J Med Microbiol 25:121–125[CrossRef]
SinhaM.,
SrinivasaH.,
MacadenR.2007; Antibiotic resistance profile and extended spectrum beta-lactamase (ESBL) production in Acinetobacter species. Indian J Med Res 126:63–67
VilaJ.,
MarcosM. A.,
Jimenez de AntaM. T.1996; A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J Med Microbiol 44:482–489[CrossRef]
YumJ. H.,
YiK.,
LeeH.,
YongD.,
LeeK.,
KimJ. M.,
RossoliniG. M.,
ChongY.2002; Molecular characterization of metallo- β -lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two novel integrons carrying bla VIM-2 gene cassettes. J Antimicrob Chemother 49:837–840[CrossRef]
Phenotypic and genotypic assays for detecting the prevalence of metallo-β-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital